Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
259,967,612
-
Number of holders
-
868
-
Total 13F shares, excl. options
-
172,345,023
-
Shares change
-
-1,278,747
-
Total reported value, excl. options
-
$5,652,550,434
-
Value change
-
-$22,914,654
-
Put/Call ratio
-
1.03%
-
Number of buys
-
324
-
Number of sells
-
-612
-
Price
-
$32.79
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q3 2021
1,069 filings reported holding OGN - Organon & Co. - Common Stock as of Q3 2021.
Organon & Co. - Common Stock (OGN) has 868 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 172,345,023 shares
of 259,967,612 outstanding shares and own 66.29% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (28,808,686 shares), BlackRock Inc. (16,618,154 shares), STATE STREET CORP (9,017,819 shares), Bank of New York Mellon Corp (5,298,787 shares), JANUS HENDERSON GROUP PLC (5,281,621 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (4,895,424 shares), GEODE CAPITAL MANAGEMENT, LLC (4,772,711 shares), WELLINGTON MANAGEMENT GROUP LLP (4,368,836 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (4,248,129 shares), and JPMORGAN CHASE & CO (3,242,545 shares).
This table shows the top 868 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.